English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Stem cell study identifies universal checkpoint controlling cell identity
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Study finds genetic links between psychiatric disorders and physical illnesses
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Gilead Sciences to focus on integration after three major acquisitions in 2026
+ Pharmaceuticals
Patient Daily | Apr 19, 2026

Study finds social support and physical health boost mental well-being in older Canadians
+ Pharmaceuticals
Patient Daily | Apr 17, 2026

Nanomedicine offers targeted solutions for breast cancer treatment
+ Pharmaceuticals
Patient Daily | Apr 17, 2026

Insilico Medicine announces Pharma AI Spring Kickoff 2026 webinar for April 14
+ Pharmaceuticals
Patient Daily | Apr 17, 2026

Study finds longevity gains across all U.S. states for people born 1941 to 2000
+ Pharmaceuticals
Patient Daily | Apr 17, 2026

Review outlines safety considerations for CRISPR-based gene therapies

Trending
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'
Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation
+ Pharmaceuticals
Patient Daily | Aug 7, 2026

Researchers develop computer model linking brain chemistry to neural activity patterns